Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Zoledronic Acid for Injection 4 mg
  Indications :
 

Hypercalcemia of Malignancy

Multiple Myeloma and Bone Metastases of Solid Tumors

   
  Dosage :
  Hypercalcemia of Malignancy :
4-mg dose as a single-dose intravenous infusion over a period not less than 15 minutes.

Multiple Myeloma and Bone Metastases of Solid Tumors :
4 mg infused over a period not less than 15 minutes, every three to four weeks.

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : Not Required.
   
  Packing : 5 Vials of 4 mg
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.